OELKE MATHIAS 4
4 · NexImmune, Inc. · Filed Nov 25, 2022
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
OELKE MATHIAS
Chief Science Officer
Transactions
- Award
Common Stock
2022-11-22+126,100→ 134,023 total
Footnotes (2)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest 100% on the 18-month anniversary of the grant date, subject to Mr. Oelke's continued service through the applicable vesting date.
- [F2]Excludes 223,634 shares of common stock underlying options that are currently exercisable.